|
Re: Up front Payment
|
2
|
Resverlogix Corp.
|
Sep 26, 2020 08:32AM
|
|
Re: Up front Payment
|
2
|
Resverlogix Corp.
|
Sep 26, 2020 09:47AM
|
|
Re: Up front Payment
|
2
|
Resverlogix Corp.
|
Sep 26, 2020 11:25AM
|
|
Re: Up 08 cents
|
1
|
Resverlogix Corp.
|
Jun 09, 2020 12:34PM
|
|
Re: Under the radar....
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2020 06:42PM
|
|
Re: Under the radar....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 17, 2020 03:30PM
|
|
Re: Under the radar....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2020 09:51AM
|
|
Re: Under the radar....
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2020 01:05PM
|
|
Re: two things most believe
|
|
Resverlogix Corp.
|
Sep 09, 2021 09:07AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
|
Zenith Epigenetics
|
Sep 04, 2018 05:52AM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
2
|
Zenith Epigenetics
|
Sep 02, 2018 01:11PM
|
|
Re: Two more clinical study sites added to the ZEN-3694/enzalutamid... mCRPC trial
|
2
|
Zenith Epigenetics
|
Sep 03, 2018 06:06AM
|
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
1
|
Resverlogix Corp.
|
Apr 15, 2020 10:19AM
|
|
Re: Two big thank you’s
|
|
Zenith Epigenetics
|
Nov 24, 2022 04:33PM
|
|
Re: Two big thank you’s
|
2
|
Zenith Epigenetics
|
Nov 25, 2022 07:18AM
|
|
Re: Two articles - Apabetalone for Colon Cancer?
|
4
|
Resverlogix Corp.
|
Jul 09, 2021 10:58AM
|
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
Jun 02, 2020 08:05AM
|
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
Jun 01, 2020 05:49AM
|
|
Re: Tweet from Prof Kausik Ray
|
4
|
Resverlogix Corp.
|
Jun 01, 2020 10:26AM
|
|
Re: Tweet from Prof Kausik Ray
|
2
|
Resverlogix Corp.
|
Jun 01, 2020 11:44AM
|
